ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Therapy and Prostate Cancer
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Jinzang" data-source="post: 170702" data-attributes="member: 12925"><p>The study described in <a href="https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/116100-testosterone-therapy-in-relation-to-prostate-cancer-in-a-us-commercial-insurance-claims-database.amp.html" target="_blank">this article</a> found a lower risk of prostate cancer in men on testosterone therapy.</p><p></p><p>"We conducted a study assess whether testosterone therapy (TT) alters prostate cancer risk using a large US commercial insurance research database. From the HealthCore Integrated Research Database (HIRDSM), we selected men aged 30 years or greater who were new users of TT during 2007-2015. We selected two comparison groups: 1) unexposed (matched 10:1); 2) new users of phosphodiesterase type 5 inhibitor (PDE5i).</p><p></p><p>"The adjusted prostate cancer IRR was 0.77 (95%CI: 0.68, 0.86) when comparing TT with the unexposed group and 0.85 (95%CI: 0.79, 0.91) in comparison with the PDE5i group. Inverse associations between TT and prostate cancer were observed in a majority of subgroup analyses, although in both comparisons estimates generally attenuated with increasing time following initial exposure. Amongst TT users, duration of exposure was not associated with prostate cancer.</p><p></p><p>"Men who received TT did not have a higher rate of prostate cancer compared with the unexposed or PDE5i comparison groups. The inverse association between TT and prostate cancer could be the result of residual confounding, contraindication bias, or undefined biologic effect.</p><p></p><p>"This study suggests that limited TT exposure does not increase risk of prostate cancer in the short-term."</p></blockquote><p></p>
[QUOTE="Jinzang, post: 170702, member: 12925"] The study described in [URL='https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/116100-testosterone-therapy-in-relation-to-prostate-cancer-in-a-us-commercial-insurance-claims-database.amp.html']this article[/URL] found a lower risk of prostate cancer in men on testosterone therapy. "We conducted a study assess whether testosterone therapy (TT) alters prostate cancer risk using a large US commercial insurance research database. From the HealthCore Integrated Research Database (HIRDSM), we selected men aged 30 years or greater who were new users of TT during 2007-2015. We selected two comparison groups: 1) unexposed (matched 10:1); 2) new users of phosphodiesterase type 5 inhibitor (PDE5i). "The adjusted prostate cancer IRR was 0.77 (95%CI: 0.68, 0.86) when comparing TT with the unexposed group and 0.85 (95%CI: 0.79, 0.91) in comparison with the PDE5i group. Inverse associations between TT and prostate cancer were observed in a majority of subgroup analyses, although in both comparisons estimates generally attenuated with increasing time following initial exposure. Amongst TT users, duration of exposure was not associated with prostate cancer. "Men who received TT did not have a higher rate of prostate cancer compared with the unexposed or PDE5i comparison groups. The inverse association between TT and prostate cancer could be the result of residual confounding, contraindication bias, or undefined biologic effect. "This study suggests that limited TT exposure does not increase risk of prostate cancer in the short-term." [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Testosterone Therapy and Prostate Cancer
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top